Physiology of the periparturient period and its relation to severity of clinical mastitis.
Incidence of clinical mastitis is highest at drying off and during the periparturient period. Intramammary Escherichia coli infection in high-yielding cows can show a severe clinical response during the early post-partum period. Severe clinical mastitis is mainly determined by cow factors, in particular the functionality of the circulating polymorphonuclear leukocytes (PMN) which are recruited to the mammary gland during the inflammatory reaction. There is a co-incidence between the periods of highest incidence of clinical mastitis and specific structural changes in the mammary gland. During the periparturient period, marked changes in various systemic and local hormones are related to the secretory state of the mammary gland epithelium (lactogenesis). Estrogen and progesterone induce proliferation of the mammary epithelium throughout gestation and act as survival factors in different tissues, although conflicting data have been reported on their effect on PMN oxidative burst. Somatotropin (STH), responsible for maintenance of lactation in ruminants, has been shown to positively influence innate immunity and a more rapid recovery in milk production of severely affected animals. The concentration of STH, and as a result also IGF-I levels is, however, quite low during early lactation. IGF-I and its regulating binding proteins are associated with cell survival, modulation of apoptosis and functionality of PMN in humans. During early lactation, bio-availability of IGF-I is decreased, which might reduce its stimulating effects on PMN quality and functionality. PRL, concomitantly known as a lactogenic hormone and an immunoregulatory cytokine, has also been associated with modulation of the immune system. It is expected that in periparturient animals, hormone changes could interfere with the immune response and the clinical response of mastitis.
Vangroenweghe
F
F
Milk Secretion and Mastitis Research Center, Department of Physiology-Biochemistry-Biometrics, Faculty of Veterinary Medicine, Ghent University, Salisburylaan 133, 9820 Merelbeke, Belgium.
Lamote
I
I
Burvenich
C
C
D000818:Animals; D002417:Cattle; D004848:Epithelium / Q000502:physiology; D004927:Escherichia coli Infections / Q000503:physiopathology; D004958:Estradiol / Q000502:physiology; D016326:Extracellular Matrix Proteins / Q000502:physiology; D005260:Female; D013006:Growth Hormone / Q000502:physiology; D007109:Immunity; D007334:Insulin-Like Growth Factor I / Q000502:physiology; D007774:Lactation; D008321:Mammary Glands, Animal / Q000502:physiology; D008414:Mastitis, Bovine / Q000453:epidemiology / Q000382:microbiology / Q000503:physiopathology*; D009504:Neutrophils / Q000276:immunology; D036801:Parturition / Q000502:physiology*; D011388:Prolactin / Q000502:physiology
D016326:Extracellular Matrix Proteins; D004958:Estradiol; D007334:Insulin-Like Growth Factor I; D011388:Prolactin; D013006:Growth Hormone